Left ventricular hypertrophy is a marker for cardiovascular morbidity and mortality, and its regression through treatment of the underlying disorder may reduce the incidence of cardiovascular events.
Echocardiography preferred for accurate LVH detection; leaves open impact on outcomes and screening strategies.
Left ventricular hypertrophy caused by cardiovascular disease is a marker as well as a contributing factor for cardiovascular morbidity and mortality. Ventricular tachycardia, complex ventricular arrhythmias, and silent ischemia are more prevalent in patients with left ventricular hypertrophy than in those without. Echocardiography is more sensitive and more specific than electrocardiography in diagnosing the entity. Treatment of the underlying disorder may cause regression of left ventricular hypertrophy which, Framingham Heart Study data suggests, may reduce the incidence of cardiovascular events.
No takes yet. Share an insight, caveat, or question.
Wilbert S. Aronow (1990) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: